Recommended Treatment and Dosage for Procardia (Nifedipine) in Hypertension and Angina
For patients with hypertension and angina, immediate-release nifedipine (Procardia) should be dosed at 30-90 mg daily in divided doses, while extended-release formulations should be initiated at 30 mg once daily and titrated up to 30-60 mg once daily as maintenance therapy. 1
Dosing Guidelines for Nifedipine
Hypertension
- Extended-release (Procardia XL):
- Starting dose: 30 mg once daily
- Titration: Adjust over 7-14 days based on response
- Maintenance dose: 30-60 mg once daily
- Maximum recommended dose: 90 mg daily 1
- Take on an empty stomach
- Swallow tablets whole; do not crush, chew, or divide
Angina
- Immediate-release:
- Dosage: 10-30 mg three times daily 2
- Side effects: Hypotension, dizziness, flushing, nausea, constipation, edema
- Extended-release:
- Same dosing as for hypertension
- Duration of action: Long (for extended-release)
Important Clinical Considerations
Efficacy and Safety
- Nifedipine is a dihydropyridine calcium channel blocker that works by relaxing blood vessels, improving blood flow, and reducing cardiac workload
- Immediate-release nifedipine is not recommended for unstable angina/NSTEMI except with concomitant beta-blockade due to risk of reflex tachycardia 2
- For hypertensive emergencies, intravenous nicardipine is preferred over oral nifedipine 2
Combination Therapy
- For angina patients, nifedipine is often more effective when combined with beta-blockers 2, 3
- In patients with stable angina, the following combination is recommended:
- Beta-blocker (first-line, especially with prior MI or LV dysfunction)
- Add nifedipine if angina remains uncontrolled 2
Individualized Dose Titration
- Response to nifedipine is highly variable between patients
- Careful titration is essential to find the optimal dose for each patient
- Some patients respond best to lower doses (10 mg TID) while others require higher doses 4
- Monitor for hypotension, especially when initiating therapy
Contraindications and Cautions
- Avoid immediate-release nifedipine in:
- Unstable angina without beta-blockade
- Recent myocardial infarction
- Advanced aortic stenosis
- Cardiogenic shock
- Use with caution in elderly patients and those with liver impairment
- Do not co-administer with grapefruit juice (increases drug levels) 1
Special Situations
Hypertensive Emergencies
- Intravenous calcium channel blockers (nicardipine) are preferred over oral nifedipine for hypertensive emergencies 2
- If oral therapy is needed, extended-release formulations are safer than immediate-release
Elderly Patients
- Start at the lower end of the dosing range
- Monitor closely for orthostatic hypotension
- Consider potential drug interactions with other medications
Patients with Heart Failure
- Nifedipine should be used with caution in patients with heart failure
- Beta-blockers are preferred first-line agents for patients with reduced ejection fraction and angina 2
Remember that extended-release formulations provide more consistent blood levels and reduce the risk of reflex tachycardia compared to immediate-release nifedipine. Always monitor blood pressure response and adjust dosing accordingly to achieve optimal symptom control while minimizing side effects.